dac
[DOCID: f:h717eas.txt]
In the Senate of the United States,
November 15, 2001.
Resolved, That the bill from the House of Representatives (H.R.
717) entitled ``An Act to amend the Public Health Service Act to
provide for research with respect to various forms of muscular
dystrophy, including Duchenne, Becker, limb girdle, congenital,
facioscapulohumeral, myotonic, oculopharyngeal, distal, and Emery-
Dreifuss muscular dystrophies.'', do pass with the following
AMENDMENT:
Page 17, after line 6 insert:
SEC. 7. STUDY ON THE USE OF CENTERS OF EXCELLENCE AT THE NATIONAL
INSTITUTES OF HEALTH.
(a) Review.--Not later than 60 days after the date of enactment of
this Act, the Secretary of Health and Human Services shall enter into a
contract with the Institute of Medicine for the purpose of conducting a
study and making recommendations on the impact of, need for, and other
issues associated with Centers of Excellence at the National Institutes
of Health.
(b) Areas of Review.--In conducting the study under subsection (a),
the Institute of Medicine shall at a minimum consider the following:
(1) The current areas of research incorporating Centers of
Excellence (which shall include a description of such areas)
and the relationship of this form of funding mechanism to other
forms of funding for research grants, including investigator
initiated research, contracts and other types of research
support awards.
(2) The distinctive aspects of Centers of Excellence,
including the additional knowledge that may be expected to be
gained through Centers of Excellence as compared to other forms
of grant or contract mechanisms.
(3) The costs associated with establishing and maintaining
Centers of Excellence, and the record of scholarship and
training resulting from such Centers. The research and training
contributions of Centers should be assessed on their own merits
and in comparison with other forms of research support.
(4) Specific areas of research in which Centers of
Excellence may be useful, needed, or underused, as well as
areas of research in which Centers of Excellence may not be
helpful.
(5) Criteria that may be applied in determining when
Centers of Excellence are an appropriate and cost-effective
research investment and conditions that should be present in
order to consider the establishment of Centers of Excellence.
(6) Alternative research models that may accomplish results
similar to or greater than Centers of Excellence.
(c) Report.--Not later than 1 year after the date on which the
contract is entered into under subsection (a), the Institute of
Medicine shall complete the study under such subsection and submit a
report to the Secretary of Health and Human Services and the
appropriate committees of Congress that contains the results of such
study.
Attest:
Secretary.
107th CONGRESS
1st Session
H. R. 717
_______________________________________________________________________
AMENDMENT
0